Clinical Trial Update: Phase III Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric Cancer [Phase 3]

View source ↗

Summary

Phase III trial of apatinib for advanced or metastatic gastric cancer has completed and posted results in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Advanced or Metastatic Gastric Cancer | Phase 3 | Status: COMPLETED | Results posted: 2016-06-15